Real-time enrollment status for this based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT05641688 |
| Recruiting Status | Recruiting |
| Condition | Based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18F]PI-2620 is typically used for tau protein imaging in neurodegenerative diseases. Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Life Molecular Imaging Ltd |
| Last Updated on CT.gov | January 7, 2026 (Jan 7, 2026) |
As of March 2, 2026: Clinical trial NCT05641688 is currently recruiting participants. This clinical trial study for based on the limited information provided, this appears to be a diagnostic imaging study using a radiotracer. [18f]pi-2620 is typically used for tau protein imaging in neurodegenerative diseases. alzheimer's disease is actively seeking new participants at 25 locations across the United States. The study is sponsored by Life Molecular Imaging Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05641688 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05641688 was last updated Jan 7, 2026 (January 7, 2026). HelloStudys verifies this status automatically.